Solventum Corporation

SOLV ·Healthcare, Medical Devices, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Mar 30, 2026 FORM 4
4 Mar 30, 2026 FORM 4
4 Mar 30, 2026 FORM 4
4 Mar 30, 2026 FORM 4
4 Mar 30, 2026 FORM 4
DEFA14A Mar 27, 2026 DEFA14A
DEF 14A Mar 27, 2026 DEF 14A
SCHEDULE 13G/A Mar 27, 2026
8-K Mar 24, 2026 8-K
4 Mar 11, 2026 FORM 4
4 Mar 9, 2026 FORM 4
4 Mar 9, 2026 FORM 4
4 Mar 9, 2026 FORM 4
4 Mar 9, 2026 FORM 4
4 Mar 9, 2026 FORM 4
4 Mar 9, 2026 FORM 4
4 Mar 9, 2026 FORM 4
10-K Feb 27, 2026 10-K
8-K Feb 26, 2026 8-K
4 Feb 3, 2026 FORM 4
SCHEDULE 13G/A Jan 27, 2026
4 Jan 5, 2026 FORM 4
8-K Dec 16, 2025 8-K
4 Dec 3, 2025 FORM 4
4 Dec 2, 2025 FORM 4
← Newer Page 3 of 11 · 261 filings Older →